---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-004905"
form_type: "8-K"
ticker: "ORMP"
cik: "0001176309"
company_name: "ORAMED PHARMACEUTICALS INC."
filed_at: "2024-01-19T23:59:59+00:00"
generated_at: "2026-06-06T21:05:19.747593+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Director Yadin Rozov resigns from Oramed board for personal reasons

## Summary
- Yadin Rozov resigned from the Board of Directors effective January 17, 2024.
- Resignation was for personal reasons; no disagreement with company operations, policies or practices.
- No replacement or further board changes were announced.

## SEC filing metadata
- accession: 0001213900-24-004905
- form_type: 8-K
- ticker: ORMP
- cik: 0001176309
- company_name: ORAMED PHARMACEUTICALS INC.
- filed_at: 2024-01-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1176309/000121390024004905/0001213900-24-004905-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1176309/000121390024004905/ea191796-8k_oramed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-004905
- JSON: https://secwatch.observer/filing/0001213900-24-004905.json
- Plain text: https://secwatch.observer/filing/0001213900-24-004905.txt

## Key facts
- Executive change
  Yadin Rozov resigned as Director at ORAMED PHARMACEUTICALS INC..
  - Action: resigned
  - Role: Director
  source text: On January 17, 2024, Mr. Yadin Rozov, a member of the Board of Directors (the “Board”) of Oramed Pharmaceuticals Inc. (the “Company”), notified the Company of his intention to resign from the Board for personal reasons, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1176309/000121390024004905/0001213900-24-004905-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.